eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2024
vol. 26
 
Share:
Share:
Review paper

Strategies for enhancing melanoma detection in clinical practice and improving patient outcomes

Elżbieta Wójtowicz
1
,
Aleksandra Kulbat
2, 3
,
Joanna Zalasińska
1
,
Wojciech M. Wysocki
2, 3, 4

  1. Skin Cancer Unit, 5th Military Clinical Hospital in Cracow, Cracow, Poland
  2. Department of Oncological Surgery, 5th Military Clinical Hospital in Cracow, Cracow, Poland
  3. The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  4. Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Cracow University, Cracow, Poland
Family Medicine & Primary Care Review 2024; 26(3): 415–421
Online publish date: 2024/09/30
Get citation
 
PlumX metrics:
 
1. Matthews NH, Li WQ, Qureshi AA, et al. Epidemiology of Melanoma. In: Ward WH, Farma JM, eds. Cutaneous Melanoma: Etiology and Therapy. Brisbane (AU): Codon Publications; 2017.
2. Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A, et al. Cutaneous melanomas. Oncol Clin Pract 2020; 16: 163–182.
3. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120–140.
4. The Global cancer observatory, Globocan, WHO, December 2020 [cited 01.12.2021]. Available from URL: https://gco.iarc.fr/today/en.
5. Argenziano G, Briatico G, Brancaccio G, et al. Clinical Clues to Avoid Missing Melanoma When Morphology is Not Enough. Dermatol Pract Concept 2021; 11(4): e2021143, doi: 10.5826/dpc.1104143.
6. Forsea AM. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities. Dermatol Pract Concep 2020; 10(3): e2020033.
7. ECIS-European Cancer Information System. Measuring cancer burden and its time trends across Europe [cited 01.01.2019]. Available from URL: https://ecis.jrc.ec.europa.eu.
8. Alexandrescu DT. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J 2009; 15(11): 1.
9. Russo T, Lallas A, Brancaccio G, et al. No One Should Die of Melanoma: Time for This Vision to Be Realized? Dermatol Pract Concept 2019; 9(1): 1–3, doi: 10.5826/dpc.0901a01.
10. Greenwald HS, Friedman EB, Osman I. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res 2012; 22(1): 1–8.
11. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142(12): 1551–1558.
12. Segura S, Pellacani G, Puig S, et al. In vivo microscopic features of nodular melanomas: dermoscopy, confocal microscopy, and histopathologic correlates. Arch Dermatol 2008; 144(10): 1311–1320.
13. Gajda M, Kaminska-Winciorek G. Do not let to be late: overview of reasons for melanoma delayed diagnosis. Asian Pac J Cancer Prev 2014; 15(9): 3873–3877, doi: 10.7314/apjcp.2014.15.9.3873.
14. Karabeg R, Lukic D, Janjic Z, et al. The analysis of reasons for malignant skin tumors late diagnosis. Mater Sociomed 2012; 24(2): 73–75, doi: 10.5455/msm.2012.24.73-75.
15. Geller AC, Koh HK, Miller DR, et al. Use of health services before the diagnosis of melanoma: implications for early detection and screening. J Gen Intern Med 1992; 7(2): 154–157, doi: 10.1007/BF02598004.
16. Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol 2002; 46(5): 710–714, doi: 10.1067/mjd.2002.120531.
17. Argenziano G, Zalaudek I, Hofmann-Wellenhof R, et al. Total body skin examination for skin cancer screening in patients with focused symptoms. J Am Acad Dermatol 2012; 66(2): 212–219, doi: 10.1016/j.jaad.2010.12.039.
18. Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the inter-net. J Am Acad Dermatol 2003; 48: 679–693.
19. Rutkowski P, Wysocki P, Kozak K, et al. Expert recommendations on diagnostic-therapeutic management of melanoma patients. Oncol Clin Pract 2022; 18: 357–392.
20. Lallas A, Zalaudek I, Apalla Z, et al. Management rules to detect melanoma. Dermatology 2013; 226(1): 52–60, doi: 10.1159/000346645.
21. Kamińska-Winciorek G, Pilśniak A. The role of dermoscopy in dermato-oncological diagnostics – new trends and perspectives. Nowotwory J Oncol 2021; 71: 103–110, doi: 10.5603/NJO.a2021.0013.
22. Wysocki WM, Owczarek w, Dyduch G, et al. Postępowanie w przypadku podejrzanych zmian skórnych. Praktyczne wskazówki dla lekarzy specjalności nieonkologicznych. Forum Derm 2021; 7(2): 27–36, doi: 10.5603/FD.2021.0009 (in Polish).
23. Kulbat A, Richter K, Stefura T, et al. Systematic Review of Calcineurin Inhibitors and Incidence of Skin Malignancies after Kidney Transplantation in Adult Patients: A Study of 309,551 Cases. Curr Oncol 2023; 30(6): 5727–5737, doi: 10.3390/curroncol30060430.
24. Dzwierzynski WW. Melanoma Risk Factors and Prevention. Clin Plast Surg 2021; 48(4): 543–550, doi: 10.1016/j.cps.2021.05.001.
25. Lallas A, Apalla Z, Chaidemenos G. New Trends in Dermoscopy to Minimize the Risk of Missing Melanoma. J Skin Cancer 2012; 2012: 820474.
26. Lallas A, Longo C, Manfredini M, et al. Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ. JAMA Dermatol 2018; 154(4): 414–419, doi: 10.1001/jamadermatol.2017.6447.
27. Salerni G, Terán T, Alonso C, et al. The role of dermoscopy and digital dermoscopy follow-up in the clinical diagnosis of melanoma: clinical and dermoscopic features of 99 consecutive primary melanomas. Dermatol Pract Concept 2014; 4(4): 39–46, doi: 10.5826/dpc.0404a07.
28. Moscarella E, Tion I, Zalaudek I, et al. Both short-term and long-term dermoscopy monitoring is useful in detecting melanoma in patients with multiple atypical nevi. J Eur Acad Dermatol Venereol 2017; 31(2): 247–251, doi: 10.1111/jdv.13840.
29. Lallas A, Apalla Z, Ioannides D, et al. International Dermoscopy Society. Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society. Br J Dermatol 2017; 177(3): 645–655, doi: 10.1111/bjd.15339.
30. Haenssle HA, Blum A, Hofmann-Wellenhof R, et al. When all you have is a dermatoscope – start looking at the nails. Dermatol Pract Concept 2014; 4(4): 11–20, doi: 10.5826/dpc.0404a02.
31. Argenziano G, Briatico G, Brancaccio G, et al. Clinical Clues to Avoid Missing Melanoma When Morphology is Not Enough. Dermatol Pract Concept 2021; 11(4): e2021143, doi: 10.5826/dpc.1104143.
32. Longo C, Scope A, Lallas A, et al. Blue lesions. Dermatol Clin 2013; 31(4): 637–647, doi: 10.1016/j.det.2013.07.001.
33. Theodosiou G, Johansson I, Hamnerius N, et al. Naevoid Malignant Melanoma: A Diagnosis of a Naevus That You Later Regret. Acta Derm Venereol 2017; 97(6): 745–746, doi: 10.2340/00015555-2634.
34. Soon SL, Solomon AR Jr, Papadopoulos D, et al. Acral lentiginous melanoma mimicking benign disease: the Emory experience. J Am Acad Dermatol 2003; 48(2): 183–188, doi: 10.1067/mjd.2003.63.
35. Brinker TJ, Schlager G, French LE, et al. Computerassistierte Hautkrebsdiagnose: Wann kommt künstliche Intelligenz in der Praxis an? [Computer-assisted skin cancer diagnosis: Is it time for artificial intelligence in clinical practice?]. Hautarzt 2020; 71(9): 669–676, doi: 10.1007/s00105-020-04662-8 (in German).
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.